- $9.41bn
- $11.06bn
- $3.44bn
Bruker Q4 revenue beats estimates on biopharma market recovery
Brief: Bruker Q4 Adjusted EPS USD 0.59 Vs. IBES Estimate USD 0.65
Brief: Bruker Corp Expects 2026 Organic Revenue Growth Flat To Low-Single Digits
Brief: RI Research Instruments Announces Major Orders For Enabling Technology For ELI-NP
Hedge Flow: Hedge funds short healthcare providers as subsidies debate intensifies
Brief: Abcellera And Bruker Reach Global Settlement Of Patent Litigation
U.S. RESEARCH ROUNDUP-Affiliated Managers Group, Argenx SE, Cardinal Health Inc
Scientific instruments maker Bruker beats Q3 estimates, cuts FY guidance on weak demand
Brief: Bruker Corp Issues $690 Million Mandatory Convertible Preferred Stock - SEC Filing
U.S. STOCKS ON THE MOVE- Shoe Carnival, Leidos Holdings, copper miners
U.S. STOCKS ON THE MOVE- Gap, Aquestive Therapeutics, Lumentum
U.S. STOCKS ON THE MOVE-Bruker Corp, Centuri Holdings, Shoe Carnival
Bruker edges up after $600 mln convertible stock offering priced
Bruker tumbles after $600 mln convertible stock offering launched
Brief: Bruker Announces Public Offering Of $600 Million Of Mandatory Convertible Preferred Stock
Bruker falls after launching $600 mln convertible stock deal
'Big Short' investor Burry turned more bullish on second quarter
Brief: Bruker Corp Secures Multi-Year Contracts For Trace Detection
U.S. RESEARCH ROUNDUP- Axon Enterprise, Berkshire Hathaway, Idexx Laboratories